Hims & Hers Stock Soars on New Menopause Care Expansion – What Comes Next?
Hims & Hers’ women’s health platform now offers specialized menopause and perimenopause careinvestors.hims.com. The new service is aimed at improving access to hormone therapies for symptoms like hot flashes and sleep issues, expanding a platform that already serves over 500,000 women. The October 15 jump in HIMS stock was driven by the menopause announcement. Investors saw the new specialty as a major driver of future growth, helping Hims & Hers address a long-ignored need in women’s health. As Benzinga reported, the stock closed the day up about 10–13% after the newsbenzinga.com. This contrasts with modest moves earlier in the week, indicating strong investor appetite for the expansion. Volume spiked – roughly fifteen times the stock’s average daily volume – underscoring the market’s excitementbenzinga.com.